Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

News Daily News

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

Michael O'Riordan

June 20, 2025

News Daily News

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Michael O'Riordan

June 06, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Conference News ACC 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

Michael O'Riordan

April 08, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Michael O'Riordan

February 10, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

Advertisement

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Most PCIs in US Now Done With Radial Access

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content